Business
What Once Looked Like an Also-ran Therapy from Novartis Now Has a Chance to Compete with ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'What once looked like an also-ran therapy from Novartis now has a chance to compete with antiviral pills from Pfizer and Merck ...'
What once looked like an also-ran therapy from Novartis now has a chance to compete with antiviral pills from Pfizer and Merck https://t.co/JTtqs5H9SE— Bloomberg (@business) February 12, 2022
(The above story first appeared on LatestLY on Feb 12, 2022 11:16 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
